Sleep-related epileptic spiking in early Alzheimer's disease

Description of the granted funding

Recent evidence shows that about 40% of individual with early Alzheimer's Disease (AD) display epileptic events in the brain without any visible symptoms. These have gone undetected for years, since they occur during sleep, while routine EEG is taken during daytime. Importantly, sleep-related epileptic spiking is associated with faster deterioration of the disease symptoms, especially memory. An effective and well-tolerated drug treatment of this condition may delay the need for institutional care by 2-3 years. So far no clinical drug trials have been run on sleep-related epileptic spiking in AD. This study will test most suitable type of drug treatment using a new genetic AD mouse model for this condition. In addition, we will test the idea that epileptic spiking perturbs formation of long-term memories of recent events during sleep. Finally, we will determine how often epileptic spiking really occurs by home EEG-recordings with a portable EEG-recorder.
Show more

Starting year

2021

End year

2025

Granted funding

Heikki Tanila Orcid -palvelun logo
475 943 €

Funder

Research Council of Finland

Funding instrument

Academy projects

Other information

Funding decision number

340377

Fields of science

Neurosciences

Research fields

Neurotiede

Identified topics

brain, neuroscience